The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions

References

• Eye Disease case control study group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 1996;114:545–554.8619763
   PubMedGoogle Scholar
• Kaldırım HE, Yazgan S. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Int Ophthalmol. 2018;38(4):1549–1558. doi:10.1007/s10792-017-0618-z28646440
   PubMed Web of Science ®Google Scholar
• Li J, Paulus YM, Shuai Y, Fang W, Liu Q, Yuan S. New developments in the classification, pathogenesis, risk factors, natural history and treatment of branch retinal vein occlusion. J Ophthalmol. 2017;2017:4936924. doi:10.1155/2017/4936924 Epub 2017 Mar 12.
   Web of Science ®Google Scholar
• Sawada O, Ohji M. Retinal vein occlusion. Dev Ophthalmol. 2016;55:147–153. doi:10.1159/00043897126501219
   PubMedGoogle Scholar
• Ehlers JP, Kim SJ, Yeh S, et al. Therapies for macular edema associated with branch retinal vein occlusion. Ophthalmology. 2017;124(9):1412–1423. doi:10.1016/j.ophtha.2017.03.06028551163
   PubMed Web of Science ®Google Scholar
• Dimitrova G, Kato S. Color doppler imaging of retinal dieases. Survey of Ophthalmol. 2010;55(3):193–214. doi:10.1016/j.survophthal.2009.06.010
   PubMed Web of Science ®Google Scholar
• Keyser BJ, Flaharty PM, Sergott RC, Brown GC, Lieb WE, Annesley WH. Color Doppler imaging of arterial blood flow in central retinal vein occlusion. Ophthalmology. 1994;101:1357–1361.8058281
   PubMed Web of Science ®Google Scholar
• Pichot O, Gonzalvez B, Franco A, Mouillon M. Colour Doppler ultrasonography in the study of orbital and ocular vasclar diseases. J Fr Ophthalmol. 1996;19:19–31.
   PubMedGoogle Scholar
• Tranquart F, Arsene S, Giraudeau B, et al. Initial color Doppler findings in retinal vein occlusion. J Clin Ultrasound. 2000;28(1):28–33.10602102
   PubMed Web of Science ®Google Scholar
• Williamson TH, Baxter GM. Central retinal vein occlusion, an investigation by color Doppler imaging. Blood velocity characteristics and prediction of iris neovascularization. Ophthalmology. 1994;101(8):1362–1372.7520147
   PubMed Web of Science ®Google Scholar
• Fujino T, Curtin VT, Norton EWD. Experimental central retinal vein occlusion. A comparison of intraocular and extraocular occlusion. Arch Ophthalmol. 1969;81:395–406.4975380
   PubMedGoogle Scholar
• Ozbek Z, Saatci AO, Durak I, Kaynak S, Ergin MH, Oner B. Colour Doppler assessment of blood flow in eyes with central retinal vein occlusion. Ophthalmologica. 2002;216:231–234. doi:10.1159/00006385112207122
   PubMed Web of Science ®Google Scholar
• Arsene S, Giraudeau B, Le Lez ML, Pisella PJ, Pourcelot L, Tranquart F. Follow up by color Doppler imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol. 2002;86(11):1243–1247. doi:10.1136/bjo.86.11.124312386080
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001;106:148–156. doi:10.1159/00004661011815711
   PubMed Web of Science ®Google Scholar
• Pacella E, Pacella F, La torre G, et al. Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment. Clin Ter. 2012;163(6):413–422.
   PubMed Web of Science ®Google Scholar
• Bucolo C, Gozzo L, Longo L, Mansueto S, Vitale DC, Drago F. Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: a systematic review of real-world studies. J Pharmacol Sci. 2018;138(4):219–232. doi:10.1016/j.jphs.2018.11.00130503676
   PubMed Web of Science ®Google Scholar
• Platania CB, Paola LD, Leggio GM, et al. Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach. Front Pharmacol. 2015;29(6):248.
   Google Scholar
• Tilton RG, Chang KC, Lejeune WS, Stephan CC, Brock TA, Williamson JR. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Invest Ophthalmol Vis Sci. 1999;40:689–696.10067972
   PubMed Web of Science ®Google Scholar
• Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent elaxation in coronary arteries. Am J Physiol. 1993;265:586–592.
   PubMed Web of Science ®Google Scholar
• Greenberg JI, Shields DJ, Barillas SG, et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature. 2008;456:809–813. doi:10.1038/nature0742418997771
   PubMed Web of Science ®Google Scholar
• Giurdanella G, Anfuso CD, Olivieri M, et al. Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway. Biochem Pharmacol. 2015;96(3):278–287. doi:10.1016/j.bcp.2015.05.01726056075
   PubMed Web of Science ®Google Scholar
• Giurdanella G, Lazzara F, Caporarello N, et al. Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE. Biochem Pharmacol. 2017;142:145–154. doi:10.1016/j.bcp.2017.06.13028651842
   PubMed Web of Science ®Google Scholar
• Ameri H, Chader GJ, Kim JG, Sadda SR, Rao NA, Humayun MS. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci. 2007;48:5708–5715. doi:10.1167/iovs.07-073118055823
   PubMed Web of Science ®Google Scholar
• Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU. Tübingen Bevacizumab Study Group, Schraermeyer U. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol. 2007;143:995–1002. doi:10.1016/j.ajo.2007.03.00717449002
   PubMed Web of Science ®Google Scholar
• Kim KS, Chang HR, Song S. Ischaemic change after intravitreal bevacizumab (Avastin) injection for acular oedema secondary to non-ischaemic central retinal vein occlusion [letter]. Acta Ophthalmol. 2008;86:925–927. doi:10.1111/j.1755-3768.2008.01175.x18494740
   PubMed Web of Science ®Google Scholar
• Lee CS, Koh HJ. Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy [letter]. Acta Ophthalmol. 2008;86:812–813. doi:10.1111/j.1600-0420.2007.01111.x18093262
   PubMed Web of Science ®Google Scholar
• Bonnin P, Pournaras JA, Lazrak Z, et al. Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin) in neovascular age related macular degeneration. Acta Ophthalmol. 2010;88:641–645. doi:10.1111/j.1755-3768.2009.01526.x19563370
   PubMed Web of Science ®Google Scholar
• Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. Ophthalmology. 2009;116:1755–1761. doi:10.1016/j.ophtha.2009.03.01719560206
   PubMed Web of Science ®Google Scholar
• Bakbak B, Ozturk BT, Gedik S, Koktekir BE, Gonul S. Can intramuscular corticosteroid injection cause nonarteritic anterior ischemic optic neuropathy? Clin Ophthalmol. 2013;7:633–635. doi:10.2147/OPTH.S4386223569357
   PubMedGoogle Scholar
• Cekic O, Bardak Y, Tig SU, et al. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow. Int Ophthalmol. 2007;27(5):313–319. doi:10.1007/s10792-007-9080-717505781
   PubMedGoogle Scholar
• Cekic O, Bardak Y, Yesildag A. Color Doppler imaging of ocular blood flow after combined photodynamic theraphy with intravitreal triamcinolone in age-related macular degeneration. Curr Eye Res. 2011;36(2):149–153. doi:10.3109/02713683.2010.53380921158585
   PubMed Web of Science ®Google Scholar
• Granata A, Fiorini F, Andrulli S, et al. Doppler ultrasound and renal artery stenosis: an overview. J Ultrasound. 2009;12(4):133–143. doi:10.1016/j.jus.2009.09.00623397022
   PubMedGoogle Scholar
• Li JC, Jiang YX, Zhang SY, Wang L, Ouyang YS, Qi ZH. Evaluation of renal artery stenosis with hemodynamic parameters of Doppler sonography. J Vasc Surg. 2008;48(2):323–328. doi:10.1016/j.jvs.2008.03.04818644479
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Dinç H, Kapıcıoglu Z, Ugurlu S, Dayanır V, Korkmaz E. Arterial blood flow characteristics in central retinal vein occlusion and effects of panretinal photocoagulation treatment: an investigation by color Doppler imaging. Br J Ophthalmol. 1999;83(1):50–53. doi:10.1136/bjo.83.1.5010209435
   PubMed Web of Science ®Google Scholar
• Tranquart F, Arsene S, Aubert-Urena AS, et al. Doppler assessment of hemodynamic changes after hemodilution in retinal vein occlusion. J Clin Ultrasound. 1998;26(3):119–124.9502033
   PubMed Web of Science ®Google Scholar
• Williamson TH. A ‘’throttle” mechanism in the central retinal vein in the region of the lamina cribrosa. Br J Ophthalmol. 2007;91(9):1190–1193. doi:10.1136/bjo.2006.10279817005545
   PubMed Web of Science ®Google Scholar
• Anayol MA, Toklu Y, Kamberoglu EA, et al. Short-term effects of intravitreal triamcinolone acetonide injection on ocular blood flow evaluated with color doppler ultrasonography. Int J Ophthalmol. 2014;7:811–815. doi:10.3980/j.issn.2222-3959.2014.05.1325349798
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Sogawa K, Yoshida A. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab. Retina. 2014;34:2037–2043. doi:10.1097/IAE.000000000000017224896136
   PubMed Web of Science ®Google Scholar
• Sacu S, Pemp B, Weigert G, et al. Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2011;52:3046–3050. doi:10.1167/iovs.10-584221051706
   PubMed Web of Science ®Google Scholar
• Eibenberger K, Schmetterer L, Dreindl S, et al. Effects of intravitreal dexamethasone implants on retinal oxygen saturation, vessel diameter and retrobulbar blood flow velocity in ME secondary to RVO. Invest Ophthalmol Vis Sci. 2017;58:5022–5029. doi:10.1167/iovs.17-2222928973374
   PubMed Web of Science ®Google Scholar
• Reibaldi M, Pulvirenti A, Avitabile T, et al. Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents with and without topical antibiotic prophylaxis. Retina. 2018;38:1–11. doi:10.1097/IAE.0000000000001583
   PubMed Web of Science ®Google Scholar